MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
HUTCHMED (China) Limited American Depositary Shares

HCM

#1955
HUTCHMED (China) Limited - American Depositary Shares
12.3 8 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
12.38
12.38
Year Range
9.77
18.29
Daily Change
-0.32%
Monthly Change
+12.55%
6 month change
-11.57%
Year Change
-17.96%
Previous Close
12.4 2
Open
12.3 8
Low
12.3 8
High
12.3 8
Volume
8
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. Drug Manufacturers—Specialty & Generic
  5. HCM
Open full chart

Financials

Overview Statement Statistics Documents

2024

Current report, Q2 FY2024
2024.06.17
HUTCHMED (China) Ltd current report, Q2 FY2024
6-K
  • 1
  • ...
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11

News

Zacks
AZN MRK HCM
2026.08.18
AZN Ends NSCLC Study for Bispecific Antibody Over Unlikely Success
Benzinga
AZN HCM
2026.08.17
AstraZeneca Reports Mixed Lung Cancer Trial Outcomes From Three Pivotal Studies - AstraZeneca (NYSE:AZN)
Seeking Alpha
HCM
2026.07.19
Hutchmed: Bullish On Their Commercial Prospects And Pipeline Catalysts (NASDAQ:HCM)
Investing
HCM
2026.03.11
Hutchmed executives receive vested share awards
Investing
HCM
2026.03.09
Hutchmed withdraws cancer drug Tazverik in China
Investing
HCM
2026.03.06
HUTCHMED independent director to retire after eight years
Investing
HCM
2026.03.06
HUTCHMED March 2026 slides: $1.4B cash fuels ATTC platform push
Investing
HCM
2026.03.04
HUTCHMED starts trial of PI3K/PIKK-EGFR drug in solid tumors
Investing
HCM
2026.02.06
HUTCHMED to announce 2025 final results on March 5
Zacks
HCM
2026.01.07
Wall Street Analysts Predict a 55.93% Upside in HUTCHMED (HCM): Here's What You Should Know
Investing
HCM
2026.01.07
HUTCHMED stock rises after sovleplenib meets primary endpoint in Phase III trial
Benzinga
HCM NVS CRSP
2026.01.07
Positive China Trial Data Moves HUTCHMED Closer To Rare Blood Disorder Drug Filing In 2026 - HUTCHMED (China) (NASDAQ:HCM)

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stocks
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Subscribe to algo trading news
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd